But for a long time China’s people struggled to get hold of Wegovy because the country’s regulators had not approved it. Some ...

Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, to reduce the risk of non-fatal myocardial ...

The biggest threat for European pharmaceutical groups currently comes from the United States. President-elect Donald Trump ...

Novo Nordisk shifts its recruitment focus to China, expanding operations to meet rising demand for Ozempic and Wegovy in the ...

Diabetologist and Consultant Endocrinologist at the College of Medicine, University of Lagos and Lagos University Teaching Hospital, ...

The annual meeting of the American Heart Association was held this year from Nov. 16 to 18 in Chicago, drawing attendees from around the world, includ ...

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

A drug used to help Canadians lose weight has now been approved to reduce the risk of non-fatal heart attacks. Novo Nordisk ...

Health Canada has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial ...

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

The success of GLP-1R-targeting drugs highlights their viability as a treatment approach. Currently, there are four ...